Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ)
CNY 20.79
(0.43%)
CNY 20.79
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 923.3 Million | 1.97 Billion | 865.22 Million | 1.16 Billion | 981.32 Million | 866.2 Million |
| Net Income | 1.11 Billion | 909.69 Million | 762.34 Million | 619.93 Million | 635.11 Million | 607.79 Million |
| Depreciation & Amortization | 183.25 Million | 268.8 Million | 167.77 Million | 149.15 Million | 149.53 Million | 144.26 Million |
| Deferred income taxes | -4.69 Million | -8.68 Million | 1.3 Million | 15.58 Million | -2.64 Million | -9.4 Million |
| Stock-based compensation | 24.74 Million | 15.15 Million | - | - | - | - |
| Change in working capital | -450.62 Million | 748.7 Million | -55.01 Million | 367.47 Million | 162.89 Million | 128.25 Million |
| Other non-cash items | 893.35 Million | 37.09 Million | -9.87 Million | 33.3 Million | 33.78 Million | -14.1 Million |
| Investing Cash Flow | 2.58 Million | -644.43 Million | -889.72 Million | -203.84 Million | -313.68 Million | -287.14 Million |
| Investments in PPE | -149.16 Million | -152.9 Million | -118.31 Million | -212.73 Million | -374.23 Million | -320.86 Million |
| Acquisitions | 4.05 Million | 3.97 Million | -1.09 Million | 309.79 Million | 385.2 Million | -16.29 Million |
| Investment purchases | -2.12 Billion | -2.68 Billion | -1.98 Billion | -753.39 Million | -510 Million | -454 Million |
| Sales/Maturities of investments | 2.27 Billion | 2.19 Billion | 1.21 Billion | 665.21 Million | 559.58 Million | 475.97 Million |
| Other Investing Activities | 185.36 Million | 0.23 | 687.87 Thousand | -212.73 Million | -374.23 Million | 28.03 Million |
| Financing Cash Flow | -1.03 Billion | -242 Million | -309.32 Million | -783.59 Million | -427.81 Million | -251.61 Million |
| Debt repayment | -405.56 Million | -233.56 Million | -383.49 Million | -466.38 Million | -220 Million | -120.26 Million |
| Dividends payments | -584 Million | -406.73 Million | -201.9 Million | -582.42 Million | -584 Million | -299.52 Million |
| Common Stock Repurchased | - | - | - | -83.57 Million | -22.76 Million | - |
| Common Stock Issuance | - | - | - | 83.57 Million | 22.76 Million | - |
| Other Financing Activities | -42.79 Million | 408.25 Million | 286.34 Million | 276.79 Million | 393.46 Million | 168.17 Million |
| Accounts receivables | 77.04 Million | 26.33 Million | 38.44 Million | 332.37 Million | -57.22 Million | -79.65 Million |
| Accounts payables | -286.2 Million | 657.56 Million | 57.9 Million | -82.14 Million | 91.94 Million | 237.39 Million |
| Inventory | -241.47 Million | 73.49 Million | -152.66 Million | 101.65 Million | 130.81 Million | -20.07 Million |
| Other working capital | 25.66 Million | -8.68 Million | 1.3 Million | 15.58 Million | -2.64 Million | 148.33 Million |
| Cash at beginning of period | 2.39 Billion | 1.31 Billion | 1.64 Billion | 1.46 Billion | 1.22 Billion | 897.79 Million |
| Cash at end of period | 2.28 Billion | 2.39 Billion | 1.31 Billion | 1.64 Billion | 1.46 Billion | 1.22 Billion |
| Capital Expenditure | -149.16 Million | -152.9 Million | -118.31 Million | -212.73 Million | -374.23 Million | -320.86 Million |
| Effect of forex changes on cash | 231.53 Thousand | -16.94 Thousand | 0.30 | 0.23 | 99.5 Thousand | 322.46 Thousand |
| Net cash flow / Change in cash | -111.71 Million | 1.08 Billion | -333.81 Million | 182.42 Million | 239.92 Million | 327.76 Million |
| Free Cash Flow | 774.13 Million | 1.81 Billion | 746.91 Million | 957.13 Million | 607.09 Million | 545.34 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 100.5 Million | 231.14 Million | 255.18 Million | 267.95 Million | 1.11 Billion | 213.02 Million |
| Depreciation & Amortization | - | 45.12 Million | 45.12 Million | 36.97 Million | 183.25 Million | -107.01 Million |
| Deferred income taxes | - | - | - | - | -4.69 Million | -127.73 Million |
| Stock-based compensation | - | 5.21 Million | - | 24.74 Million | 24.74 Million | -10.45 Million |
| Change in working capital | - | -560.86 Million | - | -138.76 Million | -450.62 Million | 243.47 Million |
| Other non-cash items | -353.24 Million | -526.41 Million | -30.07 Million | 278.21 Million | 893.35 Million | -199.55 Million |
| Investing Cash Flow | -221.27 Million | -536.82 Million | 986.01 Million | 60.55 Million | 2.58 Million | -225.6 Million |
| Investments in PPE | -26.63 Million | -36.84 Million | -13.98 Million | -40.34 Million | -149.16 Million | -27.05 Million |
| Acquisitions | 1.08 Million | 27.46 Thousand | - | 2.84 Million | 4.05 Million | 88 Thousand |
| Investment purchases | -1.3 Billion | -1.8 Billion | - | -501.94 Million | -2.12 Billion | -400.35 Million |
| Sales/Maturities of investments | 1.1 Billion | 1.3 Billion | 1 Billion | 600 Million | 2.27 Billion | 201.72 Million |
| Other Investing Activities | 1.08 Million | -493.9 Million | 1.02 Billion | 107.93 Million | 185.36 Million | 0.98 |
| Financing Cash Flow | -27.12 Million | -914.65 Million | -1.01 Million | -7.74 Million | -1.03 Billion | -33.57 Million |
| Debt repayment | - | -10 Million | - | -405.56 Million | -405.56 Million | -30 Million |
| Dividends payments | -8.21 Million | -876.39 Million | -92.26 Thousand | -584 Million | -584 Million | -3.57 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -18.9 Million | -902.26 Million | -923.52 Thousand | 578.29 Million | -42.79 Million | -3.57 Million |
| Accounts receivables | - | -533.97 Million | - | 77.04 Million | 77.04 Million | 22.13 Million |
| Accounts payables | - | - | - | - | -286.2 Million | - |
| Inventory | - | -32.09 Million | - | -241.47 Million | -241.47 Million | 221.33 Million |
| Other working capital | - | 5.21 Million | - | 25.66 Million | 25.66 Million | - |
| Cash at beginning of period | 1.7 Billion | 3.49 Billion | 2.28 Billion | 1.72 Billion | 2.39 Billion | 1.97 Billion |
| Cash at end of period | 1.19 Billion | 1.7 Billion | 3.49 Billion | 2.28 Billion | 2.28 Billion | 1.72 Billion |
| Capital Expenditure | -26.63 Million | -36.84 Million | -13.98 Million | -40.34 Million | -149.16 Million | -27.05 Million |
| Effect of forex changes on cash | -432.66 Thousand | 30.97 Thousand | -134.37 Thousand | 140.33 Thousand | 231.53 Thousand | -161.33 Thousand |
| Net cash flow / Change in cash | -505.84 Million | -1.79 Billion | 1.2 Billion | 563.14 Million | -111.71 Million | -247.59 Million |
| Free Cash Flow | -279.37 Million | -377.23 Million | 211.12 Million | 468.84 Million | 774.13 Million | -15.31 Million |
300376
SRI
CCC
4263
8300
0JDK